Phathom Pharmaceuticals

We’re excited to have received a 3rd #FDAapproval of our first-in-class medicine! This approval is a welcomed development for #GERD patients, bringing a new treatment for heartburn relief in Non-Erosive GERD. Read more about what this means for the millions of people with this disease: https://bit.ly/4cLc2qe

PHAT helped spread holiday cheer within our local communities through meaningful donation drives! Our New Jersey team donated 228 pounds of food—equivalent to 208 meals—to the Morris County Interfaith Food Pantry Network and toured the facility to witness the impressive operation firsthand. The Chicago Team supported the Vernon Township Pantry by collecting their most needed items, including food, clothing, and household supplies. The team also gathered new and gently used winter apparel for the Buffalo Grove Police Department's Winter Wear Drive. A huge thank you to everyone who contributed—your generosity truly made a difference in helping brighten the holiday season for our neighbors in need! #PHATGivesBack #HolidayGiving #PHATimpact

We had a wonderful evening at The Galien Foundation's #PrixGalien USA Awards Ceremony celebrating the nomination of our novel GERD treatment as a “Best Pharmaceutical Product”! This prestigious recognition is a true testament to our commitment to people living with #GERD and the potential of our first-in-class medicine to transform the lives of millions living with this highly prevalent disease. It’s an honor to be considered alongside therapies and global biopharma organizations that have consistently pushed boundaries and redefined possibilities for patients in need. Thank you to the Galien Foundation for the nomination and an impactful evening, and congratulations to all of the nominees and winners!

Today we announced the submission of a Citizen Petition to the U.S. FDA formally requesting correction of the Orange Book listings for VOQUEZNA® (vonoprazan) tablets to reflect the full 10-year New Chemical Entity exclusivity period until May 3, 2032. Read more: https://bit.ly/3ZOiybQ

Phathom is pleased to be named by The Healthcare Technology Report to the list of the Top 100 Healthcare Technology Companies of 2024. We are proud to be named alongside organizations dedicated to improving health outcomes and driving innovation for patients. Congratulations to our fellow awardees! Read more: https://bit.ly/3CWs97d

As we reflect on our various activities throughout the year, we look back to October when the #PhathomPhamily came together for our annual “Paint #PHAT Pink” efforts for Breast Cancer Awareness Month. We’re proud of the awareness we helped spread and the contributions made to support breast cancer research. From wearing pink all month long to donating to various breast cancer foundations, thank you to everyone who participated and showed their support! #BreastCancerAwareness

The holiday season is upon us! If you have #GERD, you know how hard it can be to keep your symptoms under control—especially during a time when food is the centerpiece. Check out these tips to help manage your GERD during the holidays: https://bit.ly/49fgsVv

From our #PhathomPhamily to yours, we wish you a happy and safe Thanksgiving! We give thanks today and every day for our Phamily, stakeholders, patients and supporters of our mission to change the GI treatment landscape. #Thanksgiving2024

It’s officially #GERDAwarenessWeek, and we're also gearing up for the upcoming holiday season! Don't let your GERD symptoms go unchecked and keep you from enjoying all that this season has to offer. Talk to your doctor about finding a treatment that works for you and visit aboutgerd.org to learn more.

#GERDAwarenessWeek is coming up! For the 65 million Americans affected by gastroesophageal reflux disease (GERD), treating the condition is critical to help manage symptoms and prevent complications. Revisit our previous #GERDtoKnow posts and go to aboutgerd.org to learn more!